Kai Yan Mak

Activation of the Alternate Renin-Angiotensin System Correlates with the Clinical Status in Human Cirrhosis and Corrects Post Liver Transplantation

Stephen Casey, Robert Schierwagen, Kai Yan Mak, Sabine Klein, Frank Uschner, Christian Jansen, Michael Praktiknjo, Carsten Meyer, Daniel Thomas, Chandana Herath, Robert Jones, Jonel Trebicka, Peter Angus

Journal article  |  2019  |  Journal of Clinical Medicine

The small molecule drug diminazene aceturate inhibits liver injury and biliary fibrosis in mice

Indu G Rajapaksha, Kai Y Mak, Ping Huang, Louise M Burrell, Peter W Angus, Chandana B Herath

Journal article  |  2018  |  SCIENTIFIC REPORTS

The Adeno-associated Virus - A Safe and Promising Vehicle for Liver-specific Gene Therapy of Inherited and Non-inherited Disorders

Kai Y Mak, Indu G Rajapaksha, Peter W Angus, Chandana B Herath

Journal article  |  2017  |  Current Gene Therapy

ACE2 Therapy Using Adeno-associated Viral Vector Inhibits Liver Fibrosis in Mice

Kai Y Mak, Ruth Chin, Sharon C Cunningham, Miriam R Habib, Joseph Torresi, Alexandra F Sharland, Ian E Alexander, Peter W Angus, Chandana B Herath

Journal article  |  2015  |  Molecular Therapy

Role of the Alternate RAS in Liver Disease and the GI Tract

CB Herath, KY Mak, PW Angus

Book Chapter  |  2015

Dietary glycotoxins exacerbate progression of experimental fatty liver disease

Christopher Leung, Chandana B Herath, Zhiyuan Jia, Michelle Goodwin, Kai Yan Mak, Matthew J Watt, Josephine M Forbes, Peter W Angus

Journal article  |  2014  |  JOURNAL OF HEPATOLOGY

Angiotensin-(1-7) reduces the perfusion pressure response to angiotensin II and methoxamine via an endothelial nitric oxide-mediated pathway in cirrhotic rat liver

Chandana B Herath, Kai Mak, Louise M Burrell, Peter W Angus

Journal article  |  2013  |  AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY